Literature DB >> 20696138

Melatonin: a pleiotropic molecule regulating inflammation.

Flavia Radogna1, Marc Diederich, Lina Ghibelli.   

Abstract

Melatonin is a neurohormone produced by the pineal gland that regulates sleep and circadian functions. Melatonin also regulates inflammatory and immune processes acting as both an activator and inhibitor of these responses. Melatonin demonstrates endocrine, but also paracrine and autocrine effects in the leukocyte compartment: on one side, leukocytes respond to melatonin in a circadian fashion; on the other side, leukocytes are able to synthesize melatonin by themselves. With its endocrine and paracrine effects, melatonin differentially modulates pro-inflammatory enzymes, controls production of inflammatory mediators such as cytokines and leukotrienes and regulates the lifespan of leukocytes by interfering with apoptotic processes. Moreover, its potent antioxidant ability allows scavenging of oxidative stress in the inflamed tissues. The interesting timing of pro- and anti-inflammatory effects, such as those affecting lipoxygenase activity, suggests that melatonin might promote early phases of inflammation on one hand and contribute to its attenuation on the other hand, in order to avoid complications of chronic inflammation. This review aims at giving a comprehensive overview of the various inflammatory pathways regulated by this pleiotropic hormone.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20696138     DOI: 10.1016/j.bcp.2010.07.041

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  90 in total

1.  Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study.

Authors:  H Aly; H Elmahdy; M El-Dib; M Rowisha; M Awny; T El-Gohary; M Elbatch; M Hamisa; A-R El-Mashad
Journal:  J Perinatol       Date:  2014-11-13       Impact factor: 2.521

Review 2.  Advances in understanding the peripheral circadian clocks.

Authors:  Jacob Richards; Michelle L Gumz
Journal:  FASEB J       Date:  2012-06-01       Impact factor: 5.191

Review 3.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

Review 4.  Sleep Hygiene and Recovery Strategies in Elite Soccer Players.

Authors:  Mathieu Nédélec; Shona Halson; Barthélémy Delecroix; Abd-Elbasset Abaidia; Said Ahmaidi; Gregory Dupont
Journal:  Sports Med       Date:  2015-11       Impact factor: 11.136

5.  The Effect of Melatonin on Behavioral, Molecular, and Histopathological Changes in Cuprizone Model of Demyelination.

Authors:  Gelareh Vakilzadeh; Fariba Khodagholi; Tahereh Ghadiri; Amir Ghaemi; Farshid Noorbakhsh; Mohammad Sharifzadeh; Ali Gorji
Journal:  Mol Neurobiol       Date:  2015-08-27       Impact factor: 5.590

Review 6.  Circadian rhythm connections to oxidative stress: implications for human health.

Authors:  Melissa Wilking; Mary Ndiaye; Hasan Mukhtar; Nihal Ahmad
Journal:  Antioxid Redox Signal       Date:  2013-04-24       Impact factor: 8.401

Review 7.  Mechanism of the circadian clock in physiology.

Authors:  Jacob Richards; Michelle L Gumz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-04-10       Impact factor: 3.619

8.  Evaluation of enterochromaffin cells and melatonin secretion exponents in ulcerative colitis.

Authors:  Cezary Chojnacki; Maria Wiśniewska-Jarosińska; Grażyna Kulig; Ireneusz Majsterek; Russel J Reiter; Jan Chojnacki
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

Review 9.  The effects of melatonin supplementation on inflammatory markers among patients with metabolic syndrome or related disorders: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Maryam Akbari; Vahidreza Ostadmohammadi; Reza Tabrizi; Kamran B Lankarani; Seyed Taghi Heydari; Elaheh Amirani; Russel J Reiter; Zatollah Asemi
Journal:  Inflammopharmacology       Date:  2018-06-15       Impact factor: 4.473

10.  Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials.

Authors:  Wei Zhang; Xue-Yan Chen; Su-Wen Su; Qing-Zhong Jia; Tao Ding; Zhong-Ning Zhu; Tong Zhang
Journal:  Neurol Sci       Date:  2015-08-09       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.